评估光动力学疗法作为新血管AMD的辅助治疗:全面的元分析
Swara M Sarvepalli1, Ishani Kapoor2, Kubra Sarici3
1Department of Ophthalmology, Indiana University, Indianapolis, IN, USA.
概括
光动力疗法 (PDT) 与抗血管内皮生长因子 (Anti-VEGF) 注射相结合,可以改善视力,并减少新血管与年龄相关的黄斑变性 (nvAMD) 的治疗负担. 与单独使用Anti-VEGF相比,这种联合治疗显示出更高的疗效和安全性.
科学领域:
- 眼科医生 眼科 眼科
- 医疗治疗 医疗治疗
- 视网膜疾病 视网膜疾病
背景情况:
- 神经血管与年龄相关的黄斑变性 (nvAMD) 是导致视力丧失的主要原因.
- 抗血管内皮生长因子 (Anti-VEGF) 注射是对 nvAMD 的标准治疗方法.
- 辅助疗法的疗效和安全性正在不断研究,以改善患者的治疗结果.
研究的目的:
- 评估光动力学治疗 (PDT) 的作用,作为对 nvAMD 的抗VEGF 静脉内注射的辅助.
- 为了比较联合PDT和Anti-VEGF治疗与Anti-VEGF单一治疗的有效性和安全性.
主要方法:
- 在PubMed,Cochrane图书馆和ClinicalTrials.gov.gov进行了系统的文献搜索.
- 包括到2023年发表的研究,报告了nVAMD治疗的12个月结果.
- 评估的关键结果是最佳校正的视敏度 (BCVA),中枢视网膜厚度 (CRT) 和注射频率.
主要成果:
- 与单独使用Anti-VEGF相比,12个月后,Anti-VEGF和PDT联合治疗导致BCVA显著改善 (P=0.02).
- 两组之间没有观察到CRT的显著差异.
- 组合疗法组需要注射的次数显著减少 (P<0.0001),并没有增加眼部不良事件.
结论:
- 光动力疗法 (PDT) 是一个有效的辅助治疗 nvAMD 当与抗VEGF注射结合.
- 组合疗法可以改善视力敏度,减少频繁注射的需要.
- 结合PDT和Anti-VEGF治疗为管理nVAMD提供了有利的安全概况.
更多相关视频
08:54Author Spotlight: Understanding Age-Related Macular Degeneration Pathophysiology with QAF Workflow
Published on: May 26, 2023
1.3K
05:14Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
Published on: August 11, 2023
994
相关概念视频
Glaucoma: Overview
1.7K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Angle Closure Glaucoma: Treatment
1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K
Diabetic Retinopathy
55
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
55
